Ki67 Predicts Progression in Early CIN: Validation of a Multivariate Progression-Risk Model

Mostrar otras versiones (1)

This study of early CIN biopsies (25 CIN1 and 65 CIN2) with long follow-up was done to validate, in a new group of patients, the value of Ki67 immuno-quantitative features to predict high CIN grade in a follow-up biopsy (often denoted to as “progression”), as described in a previous study. Each biop...

Descripción completa

Detalles Bibliográficos
Autores principales: Kruse, Arnold-Jan, Baak, Jan P. A., Janssen, Emiel A., Kjellevold, Kjell-Henning, Fianec, Bent, Lovslett, Kjell, Bergh, Johan, Robboy, Stanley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2004
Materias:
Other
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617578/
https://www.ncbi.nlm.nih.gov/pubmed/15371653
http://dx.doi.org/10.1155/2004/108305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617578/
https://www.ncbi.nlm.nih.gov/pubmed/15371653
http://dx.doi.org/10.1155/2004/108305

Ejemplares similares